Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-29T09:48:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH banner was added announcing a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.2%
    Check dated 2026-10-22T08:46:44.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov version as v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-15T12:30:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-08T13:39:57.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 was added to the record history, replacing the previous v3.6.6 entry.
    Difference
    0.0%
    Check dated 2026-09-17T19:05:45.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the history; the previous revision, v3.6.5, has been removed from the history.
    Difference
    0.0%
    Check dated 2026-09-03T13:49:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.